Insufficient immunosuppressive treatment in patients with myasthenia gravis in the context of the possibility of new therapies — a single center experience | Synapse
April 16, 2026Neurologia i Neurochirurgia Polska0 citations
Insufficient immunosuppressive treatment in patients with myasthenia gravis in the context of the possibility of new therapies — a single center experience
The research aims to assess the adequacy of immunosuppressive treatment in myasthenia gravis patients before hospitalization.
Reviewed patient records to evaluate immunosuppressive treatment
Identified eligibility for therapeutic programs
Analyzed treatment gaps among patients admitted
Only a small percentage of patients were found eligible for therapy
Indicates prevalent inadequacy in treating myasthenia gravis prior to hospitalization
Abstract
Only a small percentage of patients are eligible for the therapeutic program as an indication of insufficient immunosuppressive treatment of MG before hospitalization.